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Mucocutaneous Telangiectasia as a Diagnostic Clue of 
Hereditary Hemorrhagic Telangiectasia: An Activin 
Receptor-Like Kinase-1 Mutation in a Korean Patient 
Jimyung Seo, Howard Chu, Jin Sung Lee1, Do Young Kim
Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, 1Department of Clinical Genetics, Yonsei 
University College of Medicine, Seoul, Korea
Dear Editor:
Hereditary hemorrhagic telangiectasia (HHT), also known 
as Osler-Weber-Rendu syndrome, is an autosomal domi-
nant vascular disorder manifested by variable-sized arte-
riovenous malformations (AVMs) of the skin, central nerv-
ous system, and respiratory, gastrointestinal, and urogen-
ital tracts1,2.
A 43-year-old woman visited our dermatology clinic with 
a 3-year history of increasing numbers of purpuric, punc-
tate, and tiny macules of the lip, oral cavity, and fingers 
(Fig. 1A∼C). The patient had no history of recurrent epis-
taxis; however, her mother had recurrent epistaxis and 
brain AVMs. No other abnormalities were detected in lab-
oratory workups, particularly to detect visceral AVMs, in-
cluding computed tomography scans of the chest and ab-
domen, brain magnetic resonance imaging, and gastro-
intestinal endoscopy. Under clinical suspicion, we per-
formed a mutation analysis for HHT in the patient and her 
mother. The mutation c.940C＞T (p.His314Tyr) in activin 
receptor-like kinase-1 (ACVRL1) was confirmed in both 
the patient and her mother, confirming the diagnosis of 
HHT (Fig. 1D). Interestingly, this genetic alteration, pre-
viously reported in a Western pedigree3, is a novel point 
mutation in a Korean family. The cutaneous lesions were 
well improved by pulsed dye laser (Fig. 2). 
Clinically, HHT is diagnosed by the Curaçao criteria, 
which include spontaneous and recurrent epistaxis, muco-
cutaneous telangiectasias, visceral AVMs, and family his-
tory of HHT in a first-degree relative1,3. HHT is definitively 
diagnosed when three of the criteria are satisfied, whereas 
a suspected diagnosis is given when two of the criteria are 
met. In molecular diagnosis, mutations are found in ap-
proximately 85% of HHT families; most of these cases in-
volve mutations in the endoglin (HHT1) or ACVRL1 
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Fig. 2. Skin lesions on the tongue 
showed excellent response after a 
single treatment using pulsed dye 
laser (Vbeam Perfecta; Candela 
Laser Corporation, Wayland, MA, 
USA): (A) before treatment and (B) 
after treatment. 
Fig. 1. (A∼C) Typical cutaneous telangiectasias at characteristic 
sites: lip, oral cavity, and fingers. (D) Presence of the mutation 
c.940C＞T (p.His314Tyr) in activin receptor-like kinase-1.
(HHT2) genes4. Mutations of the endoglin gene on chro-
mosome 9, which cause HHT1, were not detected in this 
family. The prevalence of specific vascular abnormalities 
varies according to genotype; patients with HHT1 have a 
higher prevalence of pulmonary and cerebral AVMs, 
while hepatic AVMs occur more commonly in HHT2 pa-
tients4. In our case, although the patient and her mother 
did not fulfill the criteria for a definitive diagnosis, HHT 
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was strongly suspected because of the patient’s typical 
mucocutaneous lesions. Therefore, targeted genetic testing 
for the endoglin and ACVRL1 genes should be performed 
to establish an early diagnosis if there are characteristic 
cutaneous features and/or a family history of HHT.
The cutaneous stigmata, which are characterized by an ac-
cumulation of small-caliber and superficial vessels, can 
cause cosmetic concerns and a risk for bleeding1,2,5. In our 
case, treatment with pulsed dye laser resulted in dramatic 
improvement of the skin lesions, similar to results reported 
by Halachmi et al.2. Multiple treatments and follow-up vis-
its can be necessary because of the lower response of 
HHT than non-HHT telangiectasia and the possible accu-
mulation of new vascular lesions2.
In conclusion, to initially rule out an HHT diagnosis, ge-
netic study is an available option. Because of the super-
ficial nature of vascular lesions, shorter wavelength vas-
cular lasers such as the pulsed dye laser can be consid-
ered an effective and safe treatment option for HHT. 
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Lymphoplasmacytic Plaque in Children
Jimyung Seo, Ji-Ye Kim1, Soo Hee Kim1, Sang Ho Oh
Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, 1Department of Pathology, Severance Hospital, 
Yonsei University College of Medicine, Seoul, Korea 
Dear Editor:
Fried et al.1 reported on a specific disease entity using the 
term “Pretibial lymphoplasmacytic plaque in children”.
Herein, we describe a 3-year-old girl with a 6-month his-
tory of a solitary, asymptomatic, erythematous, scaly pla-
que with some papules over the right knee (Fig. 1A). She 
had a clean medical history with no history of travel 
abroad, injury, or insect bite. The biopsy specimen was 
